The changing pattern of antimicrobial resistance within 42 033 Escherichia coli isolates from nosocomial, community and urology patient-specific urinary tract infections, Dublin, 1999-2009

BJU International

Volumn 109, Issue 8, 2012, Pages 1198-1206

  Cullen, Ivor M ^a   Manecksha, Rustom P ^a   McCullagh, Eddie ^a   Ahmad, Sarfraz ^a   O'Kelly, Fardod ^a   Flynn, Robert J ^a   McDermott, Ted ^a   Murphy, Philip ^a   Grainger, Ronald ^a   Fennell, Jerome P ^a   Thornhill, John A ^a  

^a ADELAIDE AND MEATH HOSPITAL   (Ireland)

Author keywords

Antibiotic; E. Coli; Resistance; Urinary tract infection

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CIPROFLOXACIN; GENTAMICIN; NITROFURANTOIN; TRIMETHOPRIM;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM DETECTION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; COMMUNICABLE DISEASE; CONTROLLED STUDY; HOSPITAL INFECTION; IRELAND; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREND STUDY; URINALYSIS; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI;

ANTI-INFECTIVE AGENTS, URINARY; COLONY COUNT, MICROBIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; INCIDENCE; IRELAND; MICROBIAL SENSITIVITY TESTS; RETROSPECTIVE STUDIES; URINARY TRACT INFECTIONS; URINE;

EID: 84859457394     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2011.10528.x     Document Type: Article

References (32)

1. Baerheim A. Empirical treatment of uncomplicated cystitis. BMJ 2001; 323: 1197-8
2. Kahlmeter G. An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project. J Antimicrob Chemother 2003; 51: 69-76 (Pubitemid 36163829)
3. Ronald A. The etiology of urinary tract infection: traditional and emerging pathogens. Dis Mon 2003; 49: 71-82 (Pubitemid 36350776)
4. Fihn SD. Clinical practice. Acute uncomplicated urinary tract infection in women. N Engl J Med 2003; 349: 259-66 (Pubitemid 36859478)
5. Warren JW. Practice guidelines for the treatment of uncomplicated cystitis. Curr Urol Rep 2001; 2: 326-9
6. Carson C, Naber KG. Role of fluoroquinolones in the treatment of serious bacterial urinary tract infections. Drugs 2004; 64: 1359-73 (Pubitemid 38916347)
7. Koeijers JJ, Verbon A, Kessels AG et al. Urinary tract infection in male general practice patients: uropathogens and antibiotic susceptibility. Urology 2010; 76: 336-40
8. Goettsch W, van Pelt W, Nagelkerke N et al. Increasing resistance to fluoroquinolones in escherichia coli from urinary tract infections in the netherlands. J Antimicrob Chemother 2000; 46: 223-8 (Pubitemid 30639291)
9. Karlowsky JA, Kelly LJ, Thornsberry C, Jones ME, Sahm DF. Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United States. Antimicrob Agents Chemother 2002; 46: 2540-5 (Pubitemid 34793461)
10. World Health Organization Report on Infectious Diseases 2000. Overcoming Antimicrobial Resistance. Available at: http://www.who.int/infectious-disease- report/2000/. Accessed 11 December 2010
11. European Community. A strategy against the microbial threat. Official Journal of the European Community. Council Resolution of 8 June 1999 on antibiotic resistance. Official Journal C 195, 13/07/1999, pp. 1-3. Available at: http://europa.eu/rapid/pressReleasesAction.do?reference=PRES/99/ 185&format=HTML&aged=0&Language=EN&guiLanguage=en. Accessed 11 December 2010
12. Gupta K. Addressing antibiotic resistance. Am J Med 2002; 113 (Suppl. 1A): 29S-34S (Pubitemid 34756643)
13. den Heijer CD, Donker GA, Maes J, Stobberingh EE. Antibiotic susceptibility of unselected uropathogenic Escherichia coli from female Dutch general practice patients: a comparison of two surveys with a 5 years interval. J Antimicrob Chemother 2010; 65: 2128-33
14. Gobernado M, Valdes L, Alos JI, Garcia-Rey C, Dal-Re R, Garcia-de-Lomas J. Antimicrobial susceptibility of clinical Escherichia coli isolates from uncomplicated cystitis in women over a 1-year period in Spain. Rev Esp Quimioter 2007; 20: 68-76 (Pubitemid 46972844)
15. Gupta K, Scholes D, Stamm WE. Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA 1999; 281: 736-8 (Pubitemid 29113455)
16. Gupta K, Hooton TM, Stamm WE. Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann Intern Med 2001; 135: 41-50 (Pubitemid 32619282)
17. Wiersma TJ, Timmermans AE. [Summary of the 'Urinary tract infections' guideline (first revision) of the Dutch College of General Practitioners]. Ned Tijdschr Geneeskd 2001; 145: 735-9
18. Kunin CM. Urinary tract infections in females. Clin Infect Dis 1994; 18: 1-10; quiz 11-2
19. Ducel G, Fabry J, Nicolle L. Prevention of Hospital Acquired Infections: A Practical Guide, 2nd edn. Geneva: World Health Organization, 2002
20. Brown PD, Freeman A, Foxman B. Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan. Clin Infect Dis 2002; 34: 1061-6 (Pubitemid 34289678)
21. EARSS Annual Report 2008. ISBN: 978-90-6960-236-3. Available at: http://www.rivm.nl/earss/result/Monitoring-reports/. Accessed 10 December 2011
22. Cheong HJ, Yoo CW, Sohn JW, Kim WJ, Kim MJ, Park SC. Bacteremia due to quinolone-resistant Escherichia coli in a teaching hospital in South Korea. Clin Infect Dis 2001; 33: 48-53
23. Junquera S, Loza E, Baquero F. [Changes in the antimicrobial susceptibility of Escherichia coli isolates from nosocomial versus community-acquired urinary tract infections]. Enferm Infecc Microbiol Clin 2005; 23: 197-201
24. Talan DA, Krishnadasan A, Abrahamian FM, Stamm WE, Moran GJ. Prevalence and risk factor analysis of trimethoprim-sulfamethoxazole- and fluoroquinolone-resistant Escherichia coli infection among emergency department patients with pyelonephritis. Clin Infect Dis 2008; 47: 1150-8
25. Nicoletti J, Kuster SP, Sulser T et al. Risk factors for urinary tract infections due to ciprofloxacin-resistant Escherichia coli in a tertiary care urology department in Switzerland. Swiss Med Wkly 2010; 140: w13059
26. Nys S, van Merode T, Bartelds AI, Stobberingh EE. Urinary tract infections in general practice patients: diagnostic tests versus bacteriological culture. J Antimicrob Chemother 2006; 57: 955-8
27. Hoogkamp-Korstanje JA, Roelofs-Willemse J. Antimicrobial resistance in Gram-negative bacteria from Intensive Care Units and Urology Services. A nationwide study in The Netherlands 1995-2000. Int J Antimicrob Agents 2003; 21: 547-56 (Pubitemid 36668008)
28. DasGupta R, Sullivan R, French G, O'Brien T. Evidence-based prescription of antibiotics in urology: a 5-year review of microbiology. BJU Int 2009; 104: 760-4
29. Mangin D, Toop L, Chambers S, Ikram R, Harris B. Increased rates of trimethoprim resistance in uncomplicated urinary tract infection: cause for concern? N Z Med J 2005; 118: U1726
30. Zhanel GG, Hisanaga TL, Laing NM et al. Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). Int J Antimicrob Agents 2006; 27: 468-75
31. Chulain MN, Murray AM, Corbett-Feeney G, Cormican M. Antimicrobial resistance in E. coli associated with urinary tract infection in the west of Ireland. Ir J Med Sci 2005; 174: 6-9 (Pubitemid 43141437)
32. Vellinga A, Murphy AW, Hanahoe B, Bennett K, Cormican M. A multilevel analysis of trimethoprim and ciprofloxacin prescribing and resistance of uropathogenic Escherichia coli in general practice. J Antimicrob Chemother 2010; 65: 1514-20